中国药物经济学
中國藥物經濟學
중국약물경제학
CHINA JOURNAL OF PHARMACEUTICAL ECONOMICS
2015年
2期
132-133
,共2页
亚低温%脑出血%术后再出血%预后
亞低溫%腦齣血%術後再齣血%預後
아저온%뇌출혈%술후재출혈%예후
Hypothermia%Cerebral hemorrhage%Postoperative bleeding%Prognosis
目的:探讨早期强化降压联合亚低温治疗对脑出血患者术后再出血和预后的影响。方法选取2013年4月至2014年4月我院收治的脑出血患者95例,随机分为研究组48例,对照组47例。对照组患者行标准降压治疗,研究组患者行早期强化降压联合亚低温治疗,分析两组患者术后再出血和预后情况。结果研究组患者术后再出血率为4.2%,明显低于对照组的29.8%;研究组患者预后优良率为85.4%,明显高于对照组的70.2%,差异均有统计学意义(均P<0.05)。结论早期强化降压联合亚低温治疗可明显降低脑出血患者术后再出血率,并改善患者预后。
目的:探討早期彊化降壓聯閤亞低溫治療對腦齣血患者術後再齣血和預後的影響。方法選取2013年4月至2014年4月我院收治的腦齣血患者95例,隨機分為研究組48例,對照組47例。對照組患者行標準降壓治療,研究組患者行早期彊化降壓聯閤亞低溫治療,分析兩組患者術後再齣血和預後情況。結果研究組患者術後再齣血率為4.2%,明顯低于對照組的29.8%;研究組患者預後優良率為85.4%,明顯高于對照組的70.2%,差異均有統計學意義(均P<0.05)。結論早期彊化降壓聯閤亞低溫治療可明顯降低腦齣血患者術後再齣血率,併改善患者預後。
목적:탐토조기강화강압연합아저온치료대뇌출혈환자술후재출혈화예후적영향。방법선취2013년4월지2014년4월아원수치적뇌출혈환자95례,수궤분위연구조48례,대조조47례。대조조환자행표준강압치료,연구조환자행조기강화강압연합아저온치료,분석량조환자술후재출혈화예후정황。결과연구조환자술후재출혈솔위4.2%,명현저우대조조적29.8%;연구조환자예후우량솔위85.4%,명현고우대조조적70.2%,차이균유통계학의의(균P<0.05)。결론조기강화강압연합아저온치료가명현강저뇌출혈환자술후재출혈솔,병개선환자예후。
Objective To explore the effect of early intensive antihypertensive combined with mild hypothermia treatment of rebleeding in patients with cerebral hemorrhage after operation and the prognosis of the patients. Methods In 95 patients from 2013 April to 2014 April in our hospital were randomly divided into cerebral hemorrhage,48 cases of the study group,47 cases in the control group.The control group underwent standard guide for antihypertensive therapy,study group underwent early intensive blood pressure lowering combined with mild hypothermia treatment,and prognosis analysis of two groups of postoperative rebleeding.Results Research group of patients with postoperative rebleeding rate was 4.2%,significantly lower than the control group of 29.8% patients;prognosis group of excellent and good rate was 85.4%,significantly higher than 70.2% in the control group,the difference was statisticaly significant(P<0.05).Conclusion Intensive blood pressure lowering combined with mild hypothermia can significantly reduce the rate of early rebleeding in patients with cerebral hemorrhage after operation,and improve the prognosis of the patients.